Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

OBJECTIVE: A subset analysis of the randomised, phase 3, MDS-004 study to evaluate outcomes in patients with International Prognostic Scoring System (IPSS)-defined Low-/Intermediate (Int)-1-risk myelodysplastic syndromes (MDS) with isolated del(5q). METHODS: Patients received lenalidomide 10 mg/d (d...

Descripción completa

Detalles Bibliográficos
Autores principales: Giagounidis, Aristoteles, Mufti, Ghulam J, Mittelman, Moshe, Sanz, Guillermo, Platzbecker, Uwe, Muus, Petra, Selleslag, Dominik, Beyne-Rauzy, Odile, te Boekhorst, Peter, del Cañizo, Consuelo, Guerci-Bresler, Agnès, Nilsson, Lars, Lübbert, Michael, Quesnel, Bruno, Ganser, Arnold, Bowen, David, Schlegelberger, Brigitte, Göhring, Gudrun, Fu, Tommy, Benettaib, Bouchra, Hellström-Lindberg, Eva, Fenaux, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232868/
https://www.ncbi.nlm.nih.gov/pubmed/24813620
http://dx.doi.org/10.1111/ejh.12380

Ejemplares similares

Ejemplares similares